Aquisition of MP Biomedicals by Valiant Co. Ltd
Mar 18, 2016
Santa Ana, California, March 18, 2016 – We are pleased to announce MP Biomedicals is now part of the Valiant Family, the acquisition of 100% membership interest of MP Biomedicals was completed on March 18. We appreciate for overall contributions from the former chairman   CEO Mr. Milan Panic and throughout the acquisition, we expect,
- MP Biomedicals's globle network to provide access to Valiant's product portfolio in many fine chemicals including Liquid Crystal materials, OLED, environmental protection materials and pharmaceuticals;
- Valiant, as a public company in China and focuses on fine chemical manufacturing, is ideally suitable to support MP's business with experienced R D team, rich manufacturing capacity and abundant funding.
In a word, we believe the merger between Valiant and MP Biomedicals are a perfect match and we will work together to create another glorious future.
More details about Valiant Co., Ltd. are available at www.valiant-cn.com